Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues	$ 680	$ 528	$ 1,867	$ 1,664
Cost of revenues	639	324	667	799
Gross profit	41	204	1,200	865
Sales and marketing expenses	112	217	532	838
General and administrative expenses	313	830	2,226	2,451
Research and development costs	195	481	788	1,311
Operating Loss	(579)	(1,324)	(2,346)	(3,735)
Impairment loss on cash surrender value of life insurance policies	(527)	0	(527)	0
Gain on accrued expense derecognition	8,300	0	8,300	0
Loss on extinguishment of debt	0	0	(27,479)	0
Gain/(loss) from change in fair value of hybrid financial instruments	6,353	17,631	11,958	4,203
Gain/(loss) from change in fair value of derivative liability - warrants	4,897	568	5,818	2,263
Gain/(loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	1,036	43,727	(13,262)	12,457
Interest expense related to convertible debt	(10)	(1,155)	(4,407)	(2,812)
Net income (loss)	19,470	59,447	(21,945)	12,376
Dividends on convertible preferred stock	0	0	0	0
Net Income (loss) available to common shareholders	19,470	59,447	(21,945)	12,376
Comprehensive income (loss):
Net Income (loss)	19,470	59,447	(21,945)	12,376
Other comprehensive loss - foreign currency translation adjustment	(3)	(19)	(18)	(32)
Comprehensive Income (loss)	$ 19,467	$ 59,428	$ (21,963)	$ 12,344
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ 0.01	$ 0.26	$ (0.02)	$ 0.13
Fully diluted (in dollars per share)	$ 0.00	$ 0.00	$ (0.02)	$ 0.00
Weighted average number of common shares:
Basic (in shares)	1,510,797,881	226,839,514	1,075,605,167	97,493,073
Fully diluted (in shares)	8,475,377,392	3,440,185,503	1,075,605,167	3,222,207,399